The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome

Experimental and Clinical Endocrinology and Diabetes

Volumn 114, Issue 4, 2006, Pages 175-181

  Hahn, Susanne ^a   Bering Van Halteren, W ^a   Roesler, S ^a   Schmidt, M ^a   Kimmig, R ^a   Tan, S ^a   Mann, K ^a   Janssen, O E ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Acne; Hirsutism; Hyperandrogenemia; Polycystic ovaries; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; BIOCHEMICAL MARKER; FOLLITROPIN; LUTEINIZING HORMONE; SOMATOMEDIN C; TESTOSTERONE;

ACNE; ADOLESCENT; ADULT; ANDROGEN BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; FOLLITROPIN BLOOD LEVEL; GERMANY; GLUCOSE METABOLISM; HIRSUTISM; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; METABOLIC DISORDER; ORAL GLUCOSE TOLERANCE TEST; OVARY FOLLICLE; OVARY FOLLICLE CELL; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; TESTOSTERONE BLOOD LEVEL; TRANSVAGINAL ECHOGRAPHY;

ADULT; FEMALE; GERMANY; HIRSUTISM; HUMANS; ORGAN SIZE; OVARIAN FOLLICLE; POLYCYSTIC OVARY SYNDROME; RETROSPECTIVE STUDIES;

EID: 33744901692     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924063     Document Type: Article

References (38)

1. Adams JM, Taylor AE, Crowley WF Jr, Hall JE. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab 2004; 89: 4343-4350
2. Aizawa H, Niimura M. Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne. J Dermatol 1995; 22: 249-252
3. Amer SA, Li TC, Bygrave C, Sprigg A, Saravelos H, Cooke ID. An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries. Hum Reprod 2002; 17: 1616-1622
4. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434-2438
5. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745-2749
6. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003; 9: 505-514
7. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab 1986; 62: 904-910
8. Bili H, Laven J, Imani B, Eijkemans MJ, Fauser BC. Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years. Eur J Endocrinol 2001; 145: 749-755
9. Cappel M, Mauger D, Thiboutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol 2005; 141: 333-338
10. Cara JF. Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production. Horm Res 1994; 42: 49-54
11. Carmina E. Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. Minerva Ginecol 2004; 56: 1-6
12. Carmina E, Wong L, Chang L, Paulson RJ, Sauer MV, Stanczyk FZ, Lobo RA. Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound. Hum Reprod 1997; 12: 905-909
13. Cela E, Robertson C, Rush K, Kousta E, White DM, Wilson H, Lyons G, Kingsley P, McCarthy MI, Franks S. Prevalence of polycystic ovaries in women with androgenic alopecia. Eur J Endocrinol 2003; 149: 439-442
14. Cussons AJ, Stuckey BG, Walsh JP, Burke V, Norman RJ. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clin Endocrinol (Oxf) 2005; 62: 289-295
15. De Leo V, Lanzetta D, D'Antona D, la Marca A, Morgante G. Hormonal effects of flutamide in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83: 99-102
16. Dramusic V, Goh VH, Rajan U, Wong YC, Ratnam SS. Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents. J Pediatr Adolesc Gynecol 1997; 10: 125-132
17. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774-800
18. ESHRE/ASRM. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25
19. Gilling-Smith C, Story H, Rogers V, Franks S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1997; 47: 93-99
20. Hassan MA, Killick SR. Ultrasound diagnosis of polycystic ovaries in women who have no symptoms of polycystic ovary syndrome is not associated with subfecundity or subfertility. Fertil Steril 2003; 80: 966-975
21. Herter LD, Magalhaes JA, Spritzer PM. Association of ovarian volume and serum LH levels in adolescent patients with menstrual disorders and/or hirsutism. Braz J Med Biol Res 1993; 26: 1041-1046
22. Iwashita M, Mimuro T, Watanabe M, Setoyama T, Matsuo A, Adachi T, Takeda Y, Sakamoto S. Plasma levels of insulin-like growth factor-1 and its binding protein in polycystic ovary syndrome. Horm Res 1990; 33: 21-26
23. Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 2004; 10: 107-117
24. Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod 2003; 18: 598-603
25. Legro RS, Chiu P, Kunselman AR, Bentley CM, Dodson WC, Dunaif A. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab 2005; 90: 2571-2579
26. Loucks TL, Talbott EO, McHugh KP, Keelan M, Berga SL, Guzick DS. Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome? Fertil Steril 2000; 74: 547-552
27. Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470
28. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
29. Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 1999; 51: 779-786
30. Najmabadi S, Wilcox JG, Acacio BD, Thornton MH, Kolb BA, Paulson RJ. The significance of polycystic-appearing ovaries versus normal-appearing ovaries in patients with polycystic ovary syndrome. Fertil Steril 1997; 67: 631-635
31. Norman RJ, Hague WM, Masters SC, Wang XJ. Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome. Hum Reprod 1995; 10: 2258-2261
32. O'Driscoll JB, Mamtora H, Higginson J, Pollock A, Kane J, Anderson DC. A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol (Oxf) 1994; 41: 231-236
33. Pache TD, de Jong FH, Hop WC, Fauser BC. Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome. Fertil Steril 1993; 59: 544-549
34. Raskauskiene D, Jones PW, Govind A, Obhrai M, Clayton RN. Do polycystic ovaries on ultrasound scan indicate decreased insulin sensitivity in sisters of women with polycystic ovary syndrome? J Clin Endocrinol Metab 2005; 90: 2063-2067
35. Takahashi K, Uchida A, Yamasaki H, Ozaki T, Kitao M. Transvaginal ultrasonic assessment of the response to clomiphene citrate in polycystic ovarian syndrome. Fertil Steril 1994; 62: 48-53
36. Thierry van Dessel HJ, Lee PD, Faessen G, Fauser BC, Giudice LC. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome. J Clin Endocrinol Metab 1999; 84: 3030-3035
37. van der Westhuizen S, van der Spuy ZM. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome. Ultrasound Obstet Gynecol 1996; 7: 335-341
38. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998; 101: 2622-2629